Early Detection of PDAC in Patients With Chronic Pancreatitis

High Efficiency of Early Detection of Synchronous Pancreatic Ductal Adenocarcinoma in Patients With Chronic Pancreatitis

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07104864

Enrollment

359

Registered

2025-08-05

Start date

2024-08-01

Completion date

2024-12-01

Last updated

2025-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pancreatitis, PDAC - Pancreatic Ductal Adenocarcinoma

Brief summary

The goal of this study is to find simple warning signs that doctors can use to spot pancreatic cancer early in people who have chronic pancreatitis.

Interventions

DIAGNOSTIC_TESThistopathological confirmation

histopathological confirmation

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

1. a confirmed diagnosis of chronic pancreatitis; (2) availability of pathological confirmation.

Exclusion criteria

1. age less than 18 years; (2) ambiguous pathology, including cases with only cytological findings or indications of pancreatic tissue alone; (3) preoperative diagnosis of PDAC or other pancreatic tumors before invasive procedure; (4) presence of tumors in other organs; (5) patients with missing data exceeding 15% of the total dataset.

Design outcomes

Primary

Measure	Time frame
pathological diagnosis of PDAC	January 2013 and December 2023

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026